Trials / Completed
CompletedNCT05141383
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- Male
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Constitution of a biological collection within the framework of the establishment of a diagnostic, prognostic and active surveillance test for prostate cancer from long non-coding RNA biomarkers, in 3 cohorts of patients, with cancer of the prostate, with suspected cancer without biopsy confirmation or with prostatic hyperplasia and healthy donors. This biological collection will also be used as a support for further researches on the identification of biomarkers and genetic markers to improve the prognosis and diagnostic management of patients with prostate pathologies.
Detailed description
Multicenter, RIPH 2 study, evaluating on 3 patient cohorts the feasibility of setting up a diagnostic test, prognosis and active surveillance of prostate cancer using long non-coding RNA biomarkers. For patients agreeing to participate in the study and having signed a consent form, during their routine care consultation in the urology department, will have a blood sample and a urine sample after prostate massage as part of the study, and if necessary, a tissue sample as part of the treatment. Patients with prostate cancer will be followed as part of their care at least annually, and their follow-up data will be collected as part of the study, without additional sampling. A blood sample and a urine sample after prostate massage will be carried out during a single consultation at the CIC Henri Mondor for
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Urine sampling | A blood sample and a urine sample after prostate massage will be carried out at baseline |
Timeline
- Start date
- 2022-05-04
- Primary completion
- 2024-09-03
- Completion
- 2024-09-03
- First posted
- 2021-12-02
- Last updated
- 2025-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05141383. Inclusion in this directory is not an endorsement.